Extracellular matrix collagen fibrils and proteoglycans (ECM)

The extracellular matrix (ECM) is a complex structural network composed primarily of collagen fibrils and associated proteoglycans (PGs) that provide mechanical support and biochemical cues to cells (Alberts B, et al., Molecular Biology of the Cell, 2002). Collagen fibrils, predominantly Types I, II, and III, form the tensile scaffold of tissues, while small leucine-rich proteoglycans (SLRPs) like decorin and biglycan decorate these fibrils to regulate their diameter and spacing (Frantz C, et al., J Cell Sci, 2010). This assembly plays a critical role in tissue homeostasis, and its dysregulation is a hallmark of diseases such as systemic fibrosis, where excessive collagen deposition leads to organ failure, and osteoarthritis, characterized by the proteolytic degradation of the ECM (NIH: Fibrosis and the ECM). Therapeutic targeting of this complex includes the use of Collagenase clostridium histolyticum to enzymatically digest collagen in Dupuytren's contracture and the development of anti-fibrotic drugs like pirfenidone that modulate ECM synthesis (StatPearls: Collagenase Clostridium Histolyticum). Furthermore, the ECM acts as a reservoir for growth factors, meaning its remodeling significantly impacts cell proliferation and migration during wound healing and cancer progression. The interaction between collagen and proteoglycans also influences mechanotransduction, where physical forces are converted into cellular signals that govern tissue repair and remodeling. In oncology, the stiffness of the collagen-PG matrix is a known driver of tumor progression and a barrier to effective drug delivery (PubMed: PMC3649538). Consequently, modulating the structural integrity of collagen fibrils and their associated proteoglycans remains a key strategy in treating chronic degenerative and fibroproliferative conditions.

Other names

Extracellular matrixECM collagen-proteoglycan complexConnective tissue matrixFibrillar collagen-SLRP complex

Enzymatic degradation of collagen peptide bonds (StatPearls: Collagenase Clostridium Histolyticum); inhibition of collagen synthesis and cross-linking via TGF-beta pathway modulation (PubMed: PMC3649538).